Gilead Sciences, Inc. (Nasdaq:GILD) announced today that its
fourth quarter and year end 2006 financial results will be released on
Wednesday, January 31, 2007, at 4:00 p.m. Eastern Time. At 4:30 p.m.
Eastern Time, Gilead will webcast a conference call live on the
company's internet site. The call will be led by John Martin, PhD,
President and Chief Executive Officer; John Milligan, PhD, Executive
Vice President and Chief Financial Officer; Norbert Bischofberger,
PhD, Executive Vice President, Research and Development; and Kevin
Young, Executive Vice President, Commercial Operations. Gilead
management will discuss the company's fourth quarter and year end 2006
results, provide an overview of the company, and an outlook and
financial guidance for 2007.
To access the webcast via the internet, log on to www.gilead.com.
Please connect to the company's website at least 15 minutes prior to
the conference call to ensure adequate time for any software download
that may be needed to hear the webcast. Alternatively, please call
1-800-901-5259 (U.S.) or 1-617-786-4514 (international) and dial the
participant passcode 19934233 to access the call. Telephone replay is
available approximately two hours after the call through 4:00 p.m.
Eastern Time, February 2, 2007. To access, please call 1-888-286-8010
(U.S.) or 1-617-801-6888 (international) and dial the participant
passcode 79206534. The webcast will be archived on www.gilead.com for
one year.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of unmet
medical need. The company's mission is to advance the care of patients
suffering from life-threatening diseases worldwide. Headquartered in
Foster City, California, Gilead has operations in North America,
Europe and Australia.
For more information on Gilead Sciences, please visit
www.gilead.com or call the Gilead Public Affairs Department at
1-800-GILEAD-5 (1-800-445-3235).
